SCHEMBL14213563

SCHEMBL14213563

O=C1/C(=C/C=C/c2ccccc2)SC(=S)N1c1ccccc1

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 10/20 0.79
MEN1 O00255 10/20 0.79
KMT2A Q03164 10/20 0.79
ALDH1A1 P00352 9/20 0.79
POLB P06746 5/20 0.79
L3MBTL1 Q9Y468 5/20 0.79
RECQL P46063 4/20 0.79
HTT P42858 3/20 0.79
NPC1 O15118 3/20 0.79
LMNA P02545 3/20 0.79
ALPG P10696 2/20 0.79
THRB P10828 2/20 0.79
RAB9A P51151 2/20 0.79
PKM P14618 2/20 0.79
NPSR1 Q6W5P4 2/20 0.79
PTPN1 P18031 1/20 0.79
PSMD14 O00487 1/20 0.79
SMN1; SMN2 Q16637 1/20 0.79
TDP1 Q9NUW8 1/20 0.79
MAPK1 P28482 3/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14213564 0.91 MAPT (0.78) MAPTMEN1KMT2AALDH1A1POLB
SCHEMBL6738029 0.89 MAPT (1.00) MAPTMEN1KMT2AALDH1A1POLB
SCHEMBL18313731 0.88 ALDH1A1 (0.64) MAPTMEN1KMT2AALDH1A1POLB
SCHEMBL14146544 0.88 ALDH1A1 (0.64) MAPTMEN1KMT2AALDH1A1POLB
SCHEMBL14213565 0.88 MAPT (0.70) MAPTMEN1KMT2AALDH1A1POLB
SCHEMBL4918105 0.83 MAPT (0.61) MAPTMEN1KMT2AALDH1A1POLB
SCHEMBL4918099 0.83 MAPT (0.61) MAPTMEN1KMT2AALDH1A1POLB
SCHEMBL30014988 0.83 MAPT (0.61) MAPTMEN1KMT2AALDH1A1POLB
SCHEMBL12123516 0.82 DUSP22 (0.77) MAPTMEN1KMT2AALDH1A1POLB
SCHEMBL9917038 0.82 DUSP22 (0.77) MAPTMEN1KMT2AALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080108677-A1 Thioxothiazolidinone Compounds For Use As Pharmaceuticals KARYON-CTT LTD (FI) 2008-05-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080108677-A1 Thioxothiazolidinone Compounds For Use As Pharmaceuticals ITGAM, ITGB1, ITGA1 MAPT 1926/4885MEN1 4099/4885KMT2A 2994/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.